Carlyle to take 20% stake in Piramal Pharma

1 July 2020 - Deborah Wilkes

Premium

Private-equity firm The Carlyle Group is taking a 20% stake in Piramal Pharma, which houses Piramal’s Consumer Products division, for around USD490 million. The investment will be used to “accelerate” Piramal Pharma’s organic and inorganic growth plans.

Click tags below for more information on topics:

Piramal

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: